Abstract Recent advances in the pathophysiologic understanding of coronavirus disease 2019 (COVID-19) suggests that cytokine release syndrome (CRS) has an association with the severity of disease, which is characterized by increased tumor necrosis factor (TNF-), interleukin (IL)-6, IL-2, IL-7, and IL-10
Both are well-studied individually in preclinical models
They improve immunotherapeutic strategies by enhancing cancer immunity in checkpoint blockade, identifying specific tumor antigens, improving safety in CAR T-cell therapy, and boosting antigenicity in DC vaccines
However, levels of these compounds can vary widely depending on the species of mushroom
There is a lot of laboratory evidence for the benefits of PRP but there is little good clinical evidence for the rotator cuff, with only small, low-powered studies
2 Though theoretically the use of NAD+ via various routes of administration for various conditions is promising, data is primarily limited to case studies at this time